Patents by Inventor Scott Michael Walsh

Scott Michael Walsh has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20090304783
    Abstract: The present invention relates to the field of bacteriology. In particular, the present invention provides compositions (e.g., comprising a lantibiotic and mupirocin or gentamicin) and methods of treating (e.g., killing or inhibiting growth of) bacteria. For example, the present invention provides pharmaceutical compositions (e.g., comprising a lantibiotic and mupirocin or gentamicin) and methods of using the same in research, therapeutic and drug screening applications.
    Type: Application
    Filed: August 17, 2009
    Publication date: December 10, 2009
    Applicant: BIOSYNEXUS INCORPORATED
    Inventors: Scott Michael Walsh, Mary Catherine Pittaway, James J. Mond
  • Patent number: 7576054
    Abstract: The present invention relates to the field of bacteriology. In particular, the present invention provides compositions (e.g., comprising a lantibiotic and mupirocin or gentamicin) and methods of treating (e.g., killing or inhibiting growth of) bacteria. For example, the present invention provides pharmaceutical compositions (e.g., comprising a lantibiotic and mupirocin or gentamicin) and methods of using the same in research, therapeutic and drug screening applications.
    Type: Grant
    Filed: October 11, 2006
    Date of Patent: August 18, 2009
    Assignee: Biosynexus Incorporated
    Inventors: Scott Michael Walsh, Mary Catherine Pittaway, James J. Mond
  • Publication number: 20090196945
    Abstract: The present invention relates to the field of bacteriology. In particular, the present invention provides compositions (e.g., comprising a lantibiotic and mupirocin or gentamicin) and methods of treating (e.g., killing or inhibiting growth of) bacteria. For example, the present invention provides pharmaceutical compounds (e.g., comprising a lantibiotic and mupirocin or gentamicin) and methods of using the same in research, therapeutic and drug screening applications.
    Type: Application
    Filed: April 13, 2009
    Publication date: August 6, 2009
    Applicant: BIOSYNEXUS INCORPORATED
    Inventors: Scott Michael Walsh, Mary Catherine Pittaway, James J. Mond
  • Patent number: 7517852
    Abstract: The present invention relates to the field of bacteriology. In particular, the present invention provides compositions (e.g., comprising a lantibiotic and mupirocin or gentamicin) and methods of treating (e.g., killing or inhibiting growth of) bacteria. For example, the present invention provides pharmaceutical compounds (e.g., comprising a lantibiotic and mupirocin or gentamicin) and methods of using the same in research, therapeutic and drug screening applications.
    Type: Grant
    Filed: July 28, 2006
    Date of Patent: April 14, 2009
    Assignee: Biosynexus Incorporated
    Inventors: Scott Michael Walsh, Mary Catherine Pittaway, James J. Mond
  • Patent number: 7138613
    Abstract: The present invention is directed to a golf ball heater comprising a rectangular container, the interior of which is outfitted with at least one heating element and rails for holding golf balls. One end of the container includes a sliding door for retrieving a heated golf ball. On one side of the container, a control box is outfitted with circuitry to cooperatively work with sensors in the container for purposes of selectively activating the heating element(s) according to whether or not the sliding door is open or shut and whether or not the temperature inside the container is within the optimal temperature range.
    Type: Grant
    Filed: July 29, 2005
    Date of Patent: November 21, 2006
    Inventors: Scott Michael Walsh, George Matthew White, James Joshua Nichols
  • Publication number: 20030224000
    Abstract: This invention provides MAbs for blocking and alleviating nasal colonization by staphylococci and methods for their use in the anterior nares.
    Type: Application
    Filed: December 20, 2002
    Publication date: December 4, 2003
    Inventors: John Fitzgerald Kokai-Kun, Jeffrey Richard Stinson, Scott Michael Walsh, Andrew Lees, James J. Mond, Gerald Walter Fischer
  • Publication number: 20030211995
    Abstract: This invention provides lysostaphin intranasal compositions that can be administered to the anterior nares of those at risk for staphylococcal nasal colonization and subsequent infection and methods for their use.
    Type: Application
    Filed: December 20, 2002
    Publication date: November 13, 2003
    Inventors: John Fitzgerald Kokai-Kun, Scott Michael Walsh, James Jacob Mond, Tatyana Ivanovna Chanturiya